Eliava BioPreparations company is developing and manufacturing therapeutic and prophylactic bacteriophage preparations for the treatment and prophylactic of bacterial infections. Currently, the company is producing six standard bacteriophage products, that are available on the market, together with several costume products, for use in a wide variety of applications. The aim of EBP is to use the unique knowledge and experience of the Eliava Institute to produce highly effective and safe bacteriophage preparations for use in human health, veterinary and environmental care. Eliava Biopreparations company received an exclusive right to use scientific developments and produce preparations developed at the Eliava Institute. Today our product proudly carries a trademark “Developed by George Eliava Institute of Bacteriophages, Microbiology, and Virology”. Eliava BioPreparations Company is the direct successor of the phage production that was operating at the Eliava Institute during the period of almost 70 years. EBP employs more than 30 scientists and phage production specialists, who work or used to work at the Eliava Institute. Phages are part of nature. Without any human involvement, hundreds of billions of phages eliminate the spread of bacteria on our planet every second, keeping the perfect balance. In today’s dynamic world, the problem of bacterial resistance is becoming one of the most challenging threats. Eliava Insitute, together with its group of companies uses bacteriophage microorganisms to target the problem of bacterial resistance against different antibacterial remedies. We have the most advanced knowledge, and longest ongoing history, for the development and use of bacteriophages for science, therapy, veterinary, environmental care, and numerous other applications. Eliava Institute has not stopped innovating for more than 90 years by now, offering modern solutions to bacterial problems.